Expression and role of V1A subunit of V-ATPases in gastric cancer cells

International Journal of Clinical Oncology

Volumn 20, Issue 4, 2015, Pages 725-735

  Liu, Pengfei ^a   Chen, Haijiao ^a   Han, Lanxiu ^a   Zou, Xiaoping ^b   Shen, Weidong ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Expression; Gastric cancer; V ATPases

Indexed keywords

ADENOSINE TRIPHOSPHATASE; KI 67 ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VACUOLAR ADENOSINE TRIPHOSPHATASE V1A; PROTEIN SUBUNIT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; CANCER TISSUE; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME SUBUNIT; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR INVASION; TUMOR VOLUME; BIOSYNTHESIS; CELL CULTURE; DISEASE COURSE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PROGNOSIS; PROTEIN SUBUNIT; STOMACH; STOMACH TUMOR; SURVIVAL; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN SUBUNITS; RNA, SMALL INTERFERING; STOMACH; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84938750584     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-015-0782-y     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
2. Ushijima T, Sasako M (2004) Focus on gastric cancer. Cancer Cell 5:121–125
3. Kapadia CR (2003) Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol 36:S29–S36
4. Hinton A, Bond S, Forgac M (2009) V-ATPase functions in normal and disease processes. Pflugers Arch—Eur J Physiol 457:589–598
5. Perez-Sayans M, Suarez-Penaranda JM, Barros-Angueira F et al (2012) An update in the structure, function, and regulation of V-ATPases: the role of the C subunit. Braz J Biol 72:189–198
6. Petzoldt AG, Gleixner EM, Fumagalli A et al (2013) Elevated expression of the V-ATPase C subunit triggers JNK-dependent cell invasion and overgrowth in a Drosophila epithelium. Dis Model Mech 6:689–700
7. Sermoune SR, Bakunis K (2004) Vacuolar H+-ATPase in human breast human cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 286:C1443–C1452
8. Sasazawa Y, Futamura Y, Tashiro E et al (2009) Vacuolar H+-ATPase inhibitors overcome Bcl-xL mediated chemoresistance through restoration of a caspase-independent apoptotic pathway. Cancer Sci 100:1460–1467
9. De Milito A, Fais S (2005) Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 1:779–786
10. Hurtado-Lorenzo A, Skinner M, El Annan J et al (2006) V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat Cell Biol 8:124–136
11. Lu X, Qin W, Li J et al (2005) The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 65:6843–6849
12. Hinton A, Bond S, Forgac M (2009) V-ATPase functions in normal and disease processes. Pflugers Arch 457:589–598
13. Clouston AD (2001) Timely topic: premalignant lesions associated with adenocarcinoma of the upper gastrointestinal tract. Pathology 33:271–277
14. Lim JH, Park JW, Kim MS et al (2006) Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha. Mol Pharmacol 70:856–865
15. Hong J, Yokomakura A, Nakano Y et al (2006) Inhibition of vacuolar-type (H+)-ATPase by the cytostatic macrolide apicularen A and its role in apicularen A-induced apoptosis in RAW 264.7 cells. FEBS Lett 580:2723–2730
16. Wojtkowiak JW, Rothberg JM, Kumar V et al (2012) Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 72:3938–3947
17. Huss M, Sasse F, Kunze B et al (2005) Archazolid and apicularen: novel specific V1A subunit of V-ATPases inhibitors. BMC Biochem 6:1–13
18. Pérez-Sayáns M, Somoza-Mart JM, Barros-Angueira F et al (2009) V-ATPases inhibitors and implication in cancer treatment. Cancer Treat Rev 35:707–713
19. Chen M, Zou X, Luo H et al (2009) Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells. Cell Biol Int 33:1008–1019
20. De Milito A, Iessi E, Logozzi M et al (2007) Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase independent mechanism involving reactive oxygen species. Cancer Res 67:5408–5417
21. Dooley CM, Schwarz H, Mueller KP et al (2013) Slc45a2 and V-ATPase are regulators of melanosomal pH homeostasis in zebrafish, providing a mechanism for human pigment evolution and disease. Pigment Cell Melanoma Res 26:205–217
22. Sennoune SR, Luo D, Martinez-Zaguilan R (2004) Plasmalemmal vacuolar-type H(+)-ATPase in cancer biology. Cell Biochem Biophys 40:185–206
23. Tabares L, Betz B (2010) Multiple functions of the vesicular proton pump in nerve terminals. Neuron 68:1020–1022
24. Beyenbach KW, Wieczorek H (2006) The V-type H+ ATPase: molecular structure and function, physiological roles and regulation. J Exp Biol 2009:577–589
25. Garcia-Garcia A, Perez-Sayans Garcia M, Rodriguez MJ et al (2012) Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa. Biotech Histochem 87:133–139